How many insider trades does FilingIQ track for CNSP?

FilingIQ tracks 48 Form 4 insider transactions for CNSP (CNS Pharmaceuticals, Inc.), covering filings from May 5, 2020 onwards. 2 of those were filed in the last 90 days.

Are CNSP insiders net buyers or net sellers?

Across the full Form 4 history for CNSP, 13 transactions (27%) were open-market purchases and 17 (35%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does CNSP insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is CNSP in?

CNS Pharmaceuticals, Inc. (CNSP) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.77M.

CNSP insider trading

NasdaqCM Healthcare

CNS Pharmaceuticals, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

27% / 35%

Market cap

$1.77M

About CNS Pharmaceuticals, Inc.

CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, develops anti-cancer drug candidates for the treatment of brain and central nervous system (CNS) tumors. The company's drug candidates include TPI 287 and Berubicin, which are in Phase 2 clinical trial for the treatment of glioblastoma and other CNS malignancies. It has license agreement with Cortice Biosciences, Inc. The company was incorporated in 2017 and is headquartered in Houston, Texas.

Company website: www.cnspharma.com

CNSP insider activity at a glance

FilingIQ has scored 48 insider transactions for CNSP since May 5, 2020. The most recent filing in our index is dated Mar 2, 2026.

Across the full history, 13 open-market purchases and 17 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on CNSP insider trades is 56.2/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live CNSP trades on FilingIQ Raw filings on SEC EDGAR

Latest CNSP Form 4 filings

Climaco John M Chief Executive Officer

P Feb 1, 2024

Downs Christopher Chief Financial Officer

P Feb 1, 2024

Downs Christopher Chief Financial Officer

P Aug 22, 2023

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for CNSP?: FilingIQ tracks 48 Form 4 insider transactions for CNSP (CNS Pharmaceuticals, Inc.), covering filings from May 5, 2020 onwards. 2 of those were filed in the last 90 days.
Are CNSP insiders net buyers or net sellers?: Across the full Form 4 history for CNSP, 13 transactions (27%) were open-market purchases and 17 (35%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does CNSP insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is CNSP in?: CNS Pharmaceuticals, Inc. (CNSP) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.77M.

Methodology & sources

Every CNSP insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.